New York A03833 requires insurance companies to cover FDA-approved antiviral therapeutics for COVID-19 at no cost to patients.

New York A03833 amends the insurance law and social services law to mandate that insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations, and medical assistance programs cover prescribed antiviral therapeutics approved by the FDA for treating COVID-19 at no cost to patients. This coverage applies to all policies and contracts issued, renewed, modified, altered, or amended on or after the bill's effective date.

New York A03833 requires insurance companies to cover FDA-approved antiviral therapeutics for COVID-19 at no cost to patients.

New York A03833 amends the insurance law and social services law to mandate that insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations, and medical assistance programs cover prescribed antiviral therapeutics approved by the FDA for treating COVID-19 at no cost to patients. This coverage applies to all policies and contracts issued, renewed, modified, altered, or amended on or after the bill's effective date.